This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 2015 Oct;49(9):794-5.

doi: 10.1097/MCG.0000000000000398.

Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric Panniculitis

Grigory Roginsky¹, Aimee Alexoff, Eli D Ehrenpreis

Affiliations

Affiliation

¹ *Department of Medicine ‡Center for the Study of Complex Diseases NorthShore University HealthSystem Evanston §Department of Gastroenterology NorthShore University HealthSystem Skokie †Department of Biology, Loyola University Chicago, Chicago, IL.

PMID: 26280708
DOI: 10.1097/MCG.0000000000000398

Clinical Trial

Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric Panniculitis

Grigory Roginsky et al. J Clin Gastroenterol. 2015 Oct.

. 2015 Oct;49(9):794-5.

doi: 10.1097/MCG.0000000000000398.

Authors

Grigory Roginsky¹, Aimee Alexoff, Eli D Ehrenpreis

Affiliation

¹ *Department of Medicine ‡Center for the Study of Complex Diseases NorthShore University HealthSystem Evanston §Department of Gastroenterology NorthShore University HealthSystem Skokie †Department of Biology, Loyola University Chicago, Chicago, IL.

PMID: 26280708
DOI: 10.1097/MCG.0000000000000398

No abstract available

PubMed Disclaimer

Similar articles

[Naltrexone--high expectations to low dosages].
Raknes G, Giverhaug T. Raknes G, et al. Tidsskr Nor Laegeforen. 2011 May 6;131(8):844-6. doi: 10.4045/tidsskr.10.1126. Tidsskr Nor Laegeforen. 2011. PMID: 21556092 Norwegian. No abstract available.
Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability.
Turel AP, Oh KH, Zagon IS, McLaughlin PJ. Turel AP, et al. J Clin Psychopharmacol. 2015 Oct;35(5):609-11. doi: 10.1097/JCP.0000000000000373. J Clin Psychopharmacol. 2015. PMID: 26203498 No abstract available.
Strategies to maximize the efficacy of naltrexone for alcohol dependence.
O'Malley SS. O'Malley SS. NIDA Res Monogr. 1995;150:53-64. NIDA Res Monogr. 1995. PMID: 8742772 No abstract available.
[Limited role of naltrexone in the treatment of opiate addiction].
van Brussel GH. van Brussel GH. Ned Tijdschr Geneeskd. 2001 Jul 28;145(30):1452-6. Ned Tijdschr Geneeskd. 2001. PMID: 11503313 Review. Dutch.
Vivitrex (Alkermes/Cephalon).
Heading CE. Heading CE. Curr Opin Investig Drugs. 2006 Jan;7(1):81-8. Curr Opin Investig Drugs. 2006. PMID: 16425675 Review.

See all similar articles

Cited by

Mesenteric Panniculitis, Sclerosing Mesenteritis and Mesenteric Lipodystrophy: Descriptive Review of a Rare Condition.
Wagner C, Dachman A, Ehrenpreis ED. Wagner C, et al. Clin Colon Rectal Surg. 2022 Aug 10;35(4):342-348. doi: 10.1055/s-0042-1743588. eCollection 2022 Jul. Clin Colon Rectal Surg. 2022. PMID: 35966977 Free PMC article. Review.
Therapeutic Uses and Efficacy of Low-Dose Naltrexone: A Scoping Review.
Leiber KK, Parker RW. Leiber KK, et al. Cureus. 2025 Mar 24;17(3):e81086. doi: 10.7759/cureus.81086. eCollection 2025 Mar. Cureus. 2025. PMID: 40271304 Free PMC article. Review.
Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization.
Toljan K, Vrooman B. Toljan K, et al. Med Sci (Basel). 2018 Sep 21;6(4):82. doi: 10.3390/medsci6040082. Med Sci (Basel). 2018. PMID: 30248938 Free PMC article. Review.
A clinician's perspective on the new organ mesentery and non-vascular mesenteropathies.
Ahmed M. Ahmed M. Front Physiol. 2024 Sep 4;15:1336908. doi: 10.3389/fphys.2024.1336908. eCollection 2024. Front Physiol. 2024. PMID: 39296517 Free PMC article. Review.
Acute Recurrent Exacerbations of Mesenteric Panniculitis With Immunosuppressive Therapy: A Case Report and a Brief Review.
Dahiya DS, Kichloo A, Singh J, Albosta MS, Wani F, Aljadah M, Haq KF. Dahiya DS, et al. J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620969581. doi: 10.1177/2324709620969581. J Investig Med High Impact Case Rep. 2020. PMID: 33138661 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources